Scientific publications
Cima Universidad de Navarra



-
- [COMBINATION STRATEGIES FOR TRANSLATIONAL IMMUNOTHERAPY]
- [APPLIED AND TRANSLATIONAL ONCO-IMMUNOLOGY]
- [IMMUNOLOGY AND IMMUNOTHERAPY]
- [CANCER DIVISION]
MHC class I and II-deficient humanized mice are suitable tools to test the long-term antitumor efficacy of immune checkpoint inhibitors and T-cell engagers
September 6, 2024 | Magazine: Journal for Immunotherapy of CancerIñaki Eguren-Santamaria 1 2 3 , Eva Fernández de Piérola 1 3 , Gracián Camps 1 3 , Paula Martín-Muñoz 1 3 , María Campos 4 , Doina Cuculescu 5 , Inmaculada Aguilera-Buenosvinos 6 , Inmaculada Rodríguez López 1 3 , Rafael Salido-Vallejo 7 , Raluca Alexandru 3 8 , Carlos E De Andrea 3 8 , Laura Álvarez-Gigli 8 , Pedro Berraondo 1 3 9 , Ignacio Melero 1 3 9 10 , Miguel F Sanmamed 11 2 3 9
-
Protein Biomarkers in Lung Cancer Screening: Technical Considerations and Feasibility Assessment
July 17, 2024 | Magazine: Archivos de BronconeumologíaDaniel Orive 1 , Mirari Echepare 2 , Franco Bernasconi-Bisio 3 , Miguel Fernández Sanmamed 4 , Antonio Pineda-Lucena 5 , Carlos de la Calle-Arroyo 6 , Frank Detterbeck 7 , Rayjean J Hung 8 , Mattias Johansson 9 , Hilary A Robbins 9 , Luis M Seijo 10 , Luis M Montuenga 11 , Karmele Valencia 12
-
- [APPLIED AND TRANSLATIONAL ONCO-IMMUNOLOGY]
- [IMMUNOLOGY AND IMMUNOTHERAPY]
- [CANCER DIVISION]
- [COMBINATION STRATEGIES FOR TRANSLATIONAL IMMUNOTHERAPY]
Short-term cultured tumor fragments to study immunotherapy combinations based on CD137 (4-1BB) agonism
July 9, 2024 | Magazine: OncoimmunologyIñaki Eguren-Santamaría 1 2 3 , Inmaculada Rodríguez 1 3 , Claudia Herrero-Martin 1 3 , Eva Fernández de Piérola 1 3 , Arantza Azpilikueta 1 3 , Sandra Sánchez-Gregorio 1 3 , Elixabet Bolaños 1 3 , Gabriel Gomis 1 3 , Paula Molero-Glez 1 3 , Enrique Chacón 4 , José Ángel Mínguez 4 , Santiago Chiva 5 , Fernando Diez-Caballero 5 , Carlos de Andrea 3 6 , Álvaro Teijeira 1 3 7 , Miguel F Sanmamed 1 2 3 7 , Ignacio Melero 3 7 8 9
-
- [COMBINATION STRATEGIES FOR TRANSLATIONAL IMMUNOTHERAPY]
- [APPLIED AND TRANSLATIONAL ONCO-IMMUNOLOGY]
- [IMMUNOLOGY AND IMMUNOTHERAPY]
- [CANCER DIVISION]
- [SOLID TUMOR]
A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors
May 10, 2023 | Magazine: Science Translational MedicineIgnacio Melero 1 2 , Tamara Tanos 3 , Mariana Bustamante 3 , Miguel F Sanmamed 1 2 4 , Emiliano Calvo 5 , Irene Moreno 5 , Victor Moreno 6 , Tatiana Hernandez 6 , Maria Martinez Garcia 7 , Alejo Rodriguez-Vida 7 , Josep Tabernero 2 8 , Analia Azaro 8 , Mariano Ponz-Sarvisé 2 4 , Iben Spanggaard 9 , Kristoffer Rohrberg 9 , Ernesto Guarin 3 , Eveline Nüesch 3 , Iakov I Davydov 3 , Chiahuey Ooi 3 , José Duarte 3 , Evelyne Chesne 3 , Christine McIntyre 10 , Maurizio Ceppi 3 , Marta Cañamero 11 , Oliver Krieter 11